4
Changes in Ownership
RESMED INC Filed Acc 0001127602-24-025362
Chief Executive Officer sold 14,683 shares at $231.91 ($3,405,206)
- Chief Executive Officer acquired 14,683 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farrell Michael J. Chief Executive Officer | 2024-10-07 | Option exercise 10b5-1 | +14,683 | $84.98 | $1,247,761 | 478,852 | D |
| Farrell Michael J. Chief Executive Officer | 2024-10-07 | Sale 10b5-1 | −14,683 | $231.91 | $3,405,206 | 464,169 | D |
| Derivatives | |||||||
| Farrell Michael J. Chief Executive Officer | 2024-10-07 | Option exercise · ResMed Common Stock Options 10b5-1 | −14,683 | 14,683 | D | ||
| Open-market sales · 14,683 sh · avg $231.91 · $3,405,206 | |||||||
Loading xslF345X05/form4.xml…